In PLOS this week: population genetics of region with high Burkitt lymphoma rates, analysis of Brazilian Chikungunya virus strains, and more.
The assay has been developed for research purposes, as a higher-throughput and lower-cost alternative to similar commercially available tests.
ScienceInsider reports that US President Donald Trump's call for more funding for childhood cancer research may focus on data sharing.
With Hi-C mapping, FISH imaging insights, and other approaches, researchers identified genome organization plasticity and between-allele variability.
The effort will also help resolve open questions about liquid biopsy sequencing's validity in clinical practice in general.
A molecular assay used in combination with patient-collected samples had similar accuracy to testing with clinician collected samples.
With several SBIR grants from the NIH, the firm is also using its Liquid Scan platform to identify neonatal trophoblast cells in maternal blood samples.
Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.
In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.
The team said it will partner with startup Early Diagnostics to commercialize the assay, which integrates DNA methylation analysis and computational technology.
Two researchers are calling for education for scientists on defending facts.
Researchers were among those who marched in London this weekend to call for another vote on Brexit.
Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant.
In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.